Search Results 1941-1950 of 26282 for stem cell

  1. Lung transplant - Doctors & Departments - Mayo Clinic

    Ex vivo lung perfusion to preserve and restore donor lungs; Stem cell therapy in lung regeneration research; Improving tests that match donors and recipients ( ...

  2. Medical Research & Education - Mayo Clinic News Network

    — Mayo Clinic's pioneering exploration of stem cell-based therapies for bone loss is headed to space. ... Engineering stem cells to treat liver disease featured ...

  3. Doctors & Departments - Mayo Clinic

    Research · Ex vivo lung perfusion to preserve and restore donor lungs · Stem cell therapy in lung regeneration research · Improving tests that match donors and ...

  4. Neuroblastoma - Survival rates - Mayo Clinic

    Stem cell transplants in cancer treatment. National Cancer Institute. https://www.cancer.gov/about-cancer/treatment/types/stem-cell-transplant. Accessed Dec ...

  5. Neurology - Clinical trials - Mayo Clinic

    The study will optimize the development of skeletal muscle cells from patient induced pluripotent stem cells (iPSCs) and to characterize their morphological, ...

  6. Neurosciences Clinical Trials - Medical Professionals

    The purpose of this research is to develop stem cells from cells within patients' skin in order to better understand peripheral neuropathy and help develop ...

  7. Mayo Clinic Transplant Center - Doctors

    Jose F. Leis, M.D., Ph.D. Internist; Hematologist. Phoenix, AZ. Areas of focus: Allogeneic stem cell transplant, Autologous stem cell transplant, Chronic ...

  8. A Study to Evaluate the Role of Gut Microbiome in Cancer Therapy - Mayo Clinic

    ... stem cell transplant. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...

  9. Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA - Mayo Clinic

    ... stem cell transplantation; Off all treatments for MDS (including AZA and DAC) ... stem cell transplant or a suitable donor cannot be found; Any active ...

  10. A Study to Assess the Effectiveness and Safety of Ublituximab in combination with Umbralisib and Venetoclax (U2-V) Compared to Ublituximab and Umbralisib (U2) in Subjects with Chronic Lymphocytic Leukemia (CLL) - Mayo Clinic

    Autologous hematologic stem cell transplant within 6 months of study entry. Prior allogeneic hematologic stem cell transplant. Evidence of chronic active ...